EKG vs WDNA: Holdings Overlap & Returns
Over the year to Nov 13, 2026, EKG returned +21.3% to WDNA's +43.3%; 9% of their weight is in the same names.
- Return gap
- +22.0 pts1 year to Nov 13, 2026: WDNA ahead, total return
- Fee gap
- 0.20 ptsA year: EKG 0.65%, WDNA 0.45%, per filings dated Jan 28, 2026 and Oct 28, 2026
- Overlap
- 9%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
EKG +21.3%, WDNA +43.3%: WDNA +22.0 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in EKG costs about $13.50 one way and $27.00 in and out, at a median spread of 0.27%. The 0.27% spread is EKG’s 30-day median, from First Trust (fund page).
Fees over time
Hypothetical. $10,000 in EKG for 10 years at 0.65% a year costs about $1,068 in fees and lost growth; WDNA at 0.45% would cost $746. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
43% of EKG's weight is in S&P 500 companies and 58% is outside the index. Holdings as of Nov 12, 2026.
26% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.
Key numbers
WDNA costs 0.20 points a year less; their one-year returns differ by 22.0 points.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +21.3% | +43.3% |
|---|---|---|
| Below its all-time high | 10.1%, high on Oct 29, 2026 | 13.9%, high on Sep 2, 2021 |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.65% | 0.45% |
| Net assets, EKG as of Nov 12, 2026 and WDNA as of Jun 30, 2026 | $9.1m | $2.7m |
| Holdings in common | 9% |
The numbers behind it
Net assets: $9.1m on Nov 12, 2026 for First Trust Nasdaq Lux Digital Health Solutions ETF, and $2.7m on Jun 30, 2026 for WisdomTree BioRevolution Fund.
Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.
What they share
By the books each fund has filed, EKG and WDNA hold 9% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.
half
9% in common
Held in common
Show all 7 holdings
| Natera, Inc. | 7.78% | 2.32% |
| Tempus AI, Inc. (Class A) | 3.11% | 2.28% |
| Twist Bioscience Corporation | 1.77% | 5.95% |
| 10X Genomics, Inc. (Class A) | 1.66% | 1.81% |
| Illumina, Inc. | 3.80% | 0.54% |
| Veracyte, Inc. | 0.45% | 1.46% |
| QIAGEN N.V. | 3.64% | 0.25% |
Only in EKG
Show all 8 holdings
| Intuitive Surgical, Inc. | 9.05% |
| Veeva Systems Inc. (Class A) | 8.20% |
| IQVIA Holdings Inc. | 8.04% |
| DexCom, Inc. | 6.93% |
| ResMed Inc. | 3.85% |
| Guardant Health, Inc. | 3.77% |
| Align Technology, Inc. | 3.23% |
| Globus Medical, Inc. (Class A) | 3.19% |
Only in WDNA
Show all 8 holdings
| MODERNA INC | 4.14% |
| ELI LILLY & COMPANY | 4.08% |
| JOHNSON & JOHNSON | 2.97% |
| UNITED THERAPEUTICS CORP | 2.45% |
| IMMUNOME INC | 2.26% |
| STRUCTURE THERAPEUTICS INC | 2.12% |
| STOKE THERAPEUTICS INC | 2.09% |
| BEAM THERAPEUTICS INC | 2.09% |
Side by side
Open the table
| Fund | First Trust Nasdaq Lux Digital Health Solutions ETF · Holds 51 stocks in healthcare innovation and GLP-1, 42% of its weight in S&P 500 companies | WisdomTree BioRevolution Fund · Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies |
| Issuer | First Trust | WisdomTree |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 42.5% | 25.9% |
| Active share vs the S&P 500 | 99.6% | 95.3% |
| In the Nasdaq-100 | 16.0% | 5.2% |
| Holdings | 51 | 80 |
| Top ten, share of the fund | 58.3% | 30.7% |
| Expense ratio | 0.65% | 0.45% |
| Fee for the differing part | 0.65% | 0.47% |
| Total return, 1 year | +21.3% | +43.3% |
| vs its benchmark | not measured | not measured |
| Below its high | −10.1% | −13.9% |
| Net assets, EKG as of Nov 12, 2026 and WDNA as of Jun 30, 2026 | $9.1m | $2.7m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +6.7% | +6.8% |
|---|---|---|
| 6 months | +43.1% | +30.6% |
| 1 year | +21.3% | +43.3% |
| 3 years | +69.3% | +62.5% |
| Since launch (Not the same days: EKG Mar 2022 · WDNA Jun 2021) | +13.3% | −3.7% |
About EKG
By weight, 42% of EKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 58% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +21.3% with distributions reinvested. It sits 10.1% below its all-time high of Oct 29, 2026.
About WDNA
By weight, 26% of WDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 31% of the fund across 80 positions, as filed for Jun 30, 2026.
More
Over the year to Nov 13, 2026 the fund returned +43.3% with distributions reinvested. It sits 13.9% below its all-time high of Sep 2, 2021.
9% of the two portfolios are the same securities at the same weight.
Questions people ask
Do EKG and WDNA hold the same stocks?
By their latest filings, 9% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, EKG against WDNA, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ekg-vs-wdna
ETFIQ. (Nov 13, 2026). EKG against WDNA. Retrieved from https://etfiq.com/compare/themes/ekg-vs-wdna
[EKG against WDNA (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ekg-vs-wdna)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.